FDA Approval for Aurobindo’s Generic Asthma Drug
New Delhi: Hyderabad-based Aurobindo Pharma is set to launch another generic drug in the US. It will release a generic version of Beclomethasone Dipropionate HFA Inhalation Aerosol for asthma patients. The US Food and Drug Administration (FDA) has granted approval for this. Arolife Pharma LLP, a wholly-owned subsidiary of Aurobindo Pharma in the US, will manufacture and market the drug within the United States.
You Might Also Like
-
Hyderabad: Dr. Reddy's Laboratories is strengthening its HIV drug portfolio. As part of this init...
-
Mumbai: Tata Motors has raised the prices of its commercial vehicles by 1 percent. The company an...
Leave A Comment
Comments